This Section's mission is to:
Section's mission is to present the benefits and risks of psychopharmacological treatment of mental disorders. The main activities are based on general and clinical pharmacology and their association with clinical trials and prudent medication use in daily practice.
- To increase interest in psychopharmacology
- To present benefits and risks of psychopharmacological treatment
- To present newest psychopharmacological treatment